Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/17/16 → 02/22/18 |
Funding
- PPD Development LP: $19,818.76
Molecular Insight Pharma: A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biopsy Proven Low-Grade Prostae Cancer who are Candidates for Active
- Adler, Howard (CoPI)
- Franceschi, Dinko (PI)
- Fitzgerald, John (CoPI)
- Liu, Jingxuan (CoPI)
- Matthews, Robert (CoPI)
- Relan, Nand (CoPI)
Project: Research